MedPath

Virtual Prism Adaptation Therapy on Hemispatial Neglect

Not Applicable
Terminated
Conditions
Virtual Reality Exposure Therapy
Perceptual Disorders
Recovery of Function
Rehabilitation
Stroke
Registration Number
NCT03771872
Lead Sponsor
Seoul National University Hospital
Brief Summary

The purpose of this study is to investigate the effect of virtual prism adaptation therapy on hemispatial neglect in chronic stroke patients. This study is the randomized, double-blind, sham-controlled, cross-over design. Total 10 patients will be allocated randomly to either real virtual prism adaptation therapy or sham therapy with the wash-out period of more than 2 weeks. Two sessions (20min/session) per day, for 5days (total 10 sessions) will be provided. Behavioral outcomes will be measured before and after completing a total of 10 sessions therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
2
Inclusion Criteria
  • 3 months after stroke onset
  • 2 or more tests indicative of hemispatial neglect in following 3 tests: 1)line bisection test, 2)Albert's test, 3)Drawing test.
  • Ability to recognize the target object, hand trajectory in the immersive virtual reality
  • 16 points or more in the Korean version of mini-mental state examination
Exclusion Criteria
  • Previous stroke or traumatic brain injury history
  • Can not cooperate during the therapy, due to delirium or aphasia
  • Unstable medical conditions
  • Severe psychiatric symptoms that interfere with the therapy participation (e.g. severe depression, agitation, psychotic symptoms)
  • Pregnancy
  • Can not maintain sitting posture

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Behavioral Inattention Test (BIT) ScoreChange from Baseline at 5 days

Range: 0(best) to 227(worst)

Secondary Outcome Measures
NameTimeMethod
BIT Conventional subtest score (BITC)Change from Baseline at 5 days

Range: 0(best) to 146(worst)

BIT Behavioral subtest score (BITB)Change from Baseline at 5 days

Range: 0(best) to 81(worst)

Catherine Bergego Scale (CBS)Change from baseline at 5 days

Range: 0 (best) to 30 (worst)

Comb and Razor TestChange from Baseline at 5 days

Range: 0% deviation (best) to 100% deviation (worst)

Trial Locations

Locations (2)

Bundang Rusk Rehabilitation Specialty Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam-si, Gyeonggi-do, Korea, Republic of

Bundang Rusk Rehabilitation Specialty Hospital
🇰🇷Seongnam-si, Gyeonggi-do, Korea, Republic of

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.